概述
The right evaluation depends on the intended use, patient population, clinical workflow, and consequences of error. A model that performs well on one dataset is not automatically ready to guide care.
主要要点
- Define context of use and responsibility.
- Evaluate representative patients, devices, and workflows.
- Treat regulatory status and model performance as specific evidence.
深入探讨
Define the clinical or operational purpose before choosing a model. A system that prioritizes records, suggests a finding, and makes a treatment recommendation have different risk profiles and evidence requirements. Identify who reviews the output, what information they see, and what happens when the system is unavailable or uncertain. Use representative data and preserve the distinction between development, validation, and real-world evaluation. Check subgroup performance, missing data, device differences, and changes in clinical practice. A retrospective result can support investigation while still falling short of evidence for prospective use. Document the model, data, version, and context of use. FDA’s AI-enabled device list emphasizes the relationship between a device’s intended use, technology, and applicable review. Regulatory status is specific to the authorized device and use; it is not a general endorsement of every model or workflow. Protect health information across inputs, logs, derived features, and outputs. Keep a qualified human decision-maker responsible for consequential care and provide a route to investigate and correct errors.
04工作示例
Separate a triage aid from a diagnosis
Imagine a model ranking 100 emergency records for review and a second system suggesting a diagnosis.
Measure whether the first ranking helps clinicians find urgent cases; do not treat that result as evidence for the second system’s diagnosis.
Test missed cases, review time, and escalation procedures before using either output in practice.
它显示了什么
This constructed example shows why healthcare evidence must match the precise intended use.
现实世界的实施
Evaluate an imaging aid on cases from the intended scanners and patient population.
Show a clinician the supporting image region and uncertainty before review.
付诸实践
为什么这很重要
- 背景与规则. 行业背景决定了人工智能创意能否与现实接触。
- 质量控制. 领域约束会影响可接受的错误率和监督模型。
- 构建选择. 成功的部署使技术能力与一线工作流程保持一致。
留意
- 监管要求可能会使原本强大的原型失效。
- 历史数据可能会编码损害特定社区的偏见。
- 遗留系统可能会造成集成瓶颈和隐性成本。
后续步骤
- 让领域专家参与从问题框架到评估的整个过程。
- 在启动前设计审计跟踪和文档。
- 尽早验证合规性和安全义务。
- 分阶段推出，并具有明确的停止和回滚标准。
资料来源与延伸阅读
不断探索
常见问题
Does FDA listing mean an AI tool is safe for every clinical use?
No. The list concerns devices authorized for particular uses and does not certify unrelated models or workflows.